UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2012

 

Commission File Number 001-33042

 

ROSETTA GENOMICS LTD.

(Translation of registrant’s name into English)

10 Plaut Street, Science Park

Rehovot 76706, Israel

(Address of Principal Executive Offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x             Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):         ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):         ¨

 

 

  

Rosetta Genomics Ltd.

 

A copy of the notice and proxy statement for the extraordinary general meeting of shareholders of Rosetta Genomics Ltd. to be held on Wednesday, December 19, 2012 is filed as Exhibit 99.1 hereto and incorporated by reference herein.

 

 

Exhibits

 

Exhibit
Number		Description of Exhibit
99.1		Notice and proxy statement relating to the extraordinary general meeting of shareholders of Rosetta Genomics Ltd. to be held on December 19, 2012.

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	ROSETTA GENOMICS LTD.
Date: November 13, 2012	By:	/s/ Oded Biran
		Oded Biran General Counsel and Secretary